IGC Pharma, Inc.IGCNYSE
Loading
Cost of Revenue Over TimeContracting
Percentile Rank27
3Y CAGR-9.3%
5Y CAGR-8.5%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-9.3%/yr
vs -31.9%/yr prior
5Y CAGR
-8.5%/yr
Consistent
Acceleration
+22.7pp
Accelerating
Percentile
P27
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $798000.00 | +22.4% |
| 2025 | $652000.00 | +6.5% |
| 2024 | $612000.00 | -42.8% |
| 2023 | $1.07M | +426.6% |
| 2022 | $203000.00 | -83.7% |
| 2021 | $1.25M | -68.5% |
| 2020 | $3.96M | -20.6% |
| 2019 | $4.98M | +136.1% |
| 2018 | $2.11M | +482.9% |
| 2017 | $362135.00 | - |